MA24499A1 - Nouveaux composes - Google Patents

Nouveaux composes

Info

Publication number
MA24499A1
MA24499A1 MA25000A MA25000A MA24499A1 MA 24499 A1 MA24499 A1 MA 24499A1 MA 25000 A MA25000 A MA 25000A MA 25000 A MA25000 A MA 25000A MA 24499 A1 MA24499 A1 MA 24499A1
Authority
MA
Morocco
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
MA25000A
Other languages
English (en)
Inventor
Mervyn Thompson
John David Harling
Barrysidney Orlek
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9705620.4A external-priority patent/GB9705620D0/en
Priority claimed from GBGB9726660.5A external-priority patent/GB9726660D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA24499A1 publication Critical patent/MA24499A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
MA25000A 1997-03-18 1998-03-16 Nouveaux composes MA24499A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9705620.4A GB9705620D0 (en) 1997-03-18 1997-03-18 Novel compounds
GBGB9726660.5A GB9726660D0 (en) 1997-12-17 1997-12-17 Novel compounds

Publications (1)

Publication Number Publication Date
MA24499A1 true MA24499A1 (fr) 1998-10-01

Family

ID=26311216

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25000A MA24499A1 (fr) 1997-03-18 1998-03-16 Nouveaux composes

Country Status (26)

Country Link
US (1) US6277861B1 (fr)
EP (1) EP0971897A1 (fr)
JP (1) JP2001516357A (fr)
KR (1) KR20000076343A (fr)
CN (1) CN1255917A (fr)
AP (1) AP9901635A0 (fr)
AR (1) AR012078A1 (fr)
AU (1) AU732162B2 (fr)
BG (1) BG103807A (fr)
BR (1) BR9809048A (fr)
CA (1) CA2283682A1 (fr)
CO (1) CO4950554A1 (fr)
DZ (1) DZ2446A1 (fr)
EA (1) EA199900836A1 (fr)
ID (1) ID22730A (fr)
IL (1) IL131958A0 (fr)
MA (1) MA24499A1 (fr)
NO (1) NO313753B1 (fr)
NZ (1) NZ337579A (fr)
OA (1) OA11390A (fr)
PE (1) PE62199A1 (fr)
PL (1) PL335675A1 (fr)
SK (1) SK126799A3 (fr)
TR (1) TR199902282T2 (fr)
TW (1) TW509679B (fr)
WO (1) WO1998041507A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016752A1 (fr) * 1997-09-30 1999-04-08 Molecular Designs International, Inc. AGONISTES DE β3-ADRENORECEPTEURS, COMPOSITIONS D'AGONISTES ET PROCEDES D'UTILISATION
GB9817424D0 (en) * 1998-08-11 1998-10-07 Smithkline Beecham Plc Novel compounds
GB9915589D0 (en) 1999-07-02 1999-09-01 Smithkline Beecham Plc Novel compounds
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
CN109608325A (zh) * 2018-12-27 2019-04-12 先尼科化工（上海）有限公司 一种卤代苯甲酸衍生物的工业化合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
ES2036213T3 (es) * 1986-10-28 1993-05-16 Smith Kline & French Laboratories Limited Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4883593A (en) * 1988-10-27 1989-11-28 Bend Research, Inc. Ultrathin-skinned asymmetric membranes by immiscible solvents treatment
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
EP0906283A1 (fr) * 1996-06-17 1999-04-07 Smithkline Beecham Plc Derives substitues du benzamide et leur utilisation comme anticonvulsivants

Also Published As

Publication number Publication date
WO1998041507A1 (fr) 1998-09-24
BG103807A (bg) 2001-05-31
CN1255917A (zh) 2000-06-07
DZ2446A1 (fr) 2003-01-11
IL131958A0 (en) 2001-03-19
CO4950554A1 (es) 2000-09-01
BR9809048A (pt) 2000-08-01
NO994504L (no) 1999-09-17
NO313753B1 (no) 2002-11-25
EA199900836A1 (ru) 2000-04-24
SK126799A3 (en) 2000-05-16
AP9901635A0 (en) 1999-09-30
OA11390A (en) 2004-04-14
AU732162B2 (en) 2001-04-12
ID22730A (id) 1999-12-09
TW509679B (en) 2002-11-11
NO994504D0 (no) 1999-09-17
NZ337579A (en) 2001-04-27
AU6412798A (en) 1998-10-12
PE62199A1 (es) 1999-09-10
TR199902282T2 (en) 2000-07-21
US6277861B1 (en) 2001-08-21
PL335675A1 (en) 2000-05-08
CA2283682A1 (fr) 1998-09-24
AR012078A1 (es) 2000-09-27
EP0971897A1 (fr) 2000-01-19
KR20000076343A (ko) 2000-12-26
JP2001516357A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
EP0802908A4 (fr) Nouveaux composes
MA24580A1 (fr) Composes dipeptidiques
FR2773155B1 (fr) Nouveaux composes fongicides
FI974141A0 (fi) Utnyttjande av innehaollet i ett meddelande
ATE250583T1 (de) Substituierte 3-cyanochinoline
ID24090A (id) Azetidina
EP1087957A4 (fr) Composes auto-inducteurs
FI974560A0 (fi) Foerfarande foer identifiering av protokolldataenheten i ett luftgraenssnitts naetskikt i ett cellulaert radionaet
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
DE59808409D1 (de) Ansaugluftverteiler
FI974133A0 (fi) Foerfarande foer faststaellande av chiffrering av en foerbindelse i ett radiosystem
FI973526A0 (fi) Foerfarande foer justering av en kompensationsdrossel i ett eldistributionsnaet
EP0999205A4 (fr) Composes d'aminocycloalcane
FR2760746B3 (fr) Nouveaux acylaminoacides
FI974453A0 (fi) Foerfarande foer foermedling av driftstyrningsfunktionerna foer ett telekommunikationssystem
FI972851A0 (fi) Foerfarande foer foermedling av datatrafik i ett telekommunikationssystem
DK0960100T3 (da) Substituerede 4-benzoyl-pyrazoler
ID20403A (id) PEMBUATAN α-TOKOFEROL
FI973579A0 (fi) Foerfarande foer uppraettande av samtal i ett traodloest abonnentnaet
MA24829A1 (fr) Nouveaux composes fongicides
FI972798A0 (fi) Foerfarande foer foermedling av datatrafik i ett telekommunikationssystem
FI972799A0 (fi) Foerfarande foer foermedling av datatrafik i ett telekommunikationssystem
ID20897A (id) Susunan penutup-rapat
FI974089A0 (fi) Foerfarande foer utfoerande av en PSTN-signaleringsanpassning i ett telekommunikationssystem
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole